Credit Suisse Downgrades VectivBio Holding to Neutral, Lowers Price Target to $17
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Tiago Fauth downgraded VectivBio Holding (NASDAQ:VECT) from Outperform to Neutral and lowered the price target from $22 to $17.
May 23, 2023 | 8:23 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
VectivBio Holding downgraded to Neutral by Credit Suisse, with a lowered price target of $17.
The downgrade from Outperform to Neutral by Credit Suisse analyst Tiago Fauth indicates a less optimistic outlook for VectivBio Holding. The lowered price target from $22 to $17 suggests a reduced potential upside for the stock, which may negatively impact its short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100